Cambridge Investment Research Advisors’s Orthofix Medical OFIX Stock Holding History

Cambridge Investment Research Advisors’s Portfolio OFIX Stock Details OFIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-10,441	Closed	-$548K	–	2325
2018 Q4	$548K	Buy	+10,441	New	+$594K	0.01%	1266
2018 Q1	–	Sell	-11,061	Closed	-$605K	–	2211
2017 Q4	$605K	Buy	+11,061	New	+$574K	0.01%	1211

Other funds holding OFIX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $8.43B AUM 52.02% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Cambridge Investment Research Advisors's OFIX Position: Q1 2019 in Review

Cambridge Investment Research Advisors sold out of Orthofix Medical (OFIX) in Q1 2019, closing a stake of 10,441 shares — an estimated $548K sold.

Cambridge Investment Research Advisors first reported a position in OFIX in Q4 2017 and held it in 2 quarters. The position peaked at $605K in Q4 2017. 172 funds tracked by Wall St. Rank hold OFIX as of Q1 2019.

Cambridge Investment Research Advisors reported no remaining Orthofix Medical position as of Q1 2019 after selling out during the quarter.
Cambridge Investment Research Advisors sold 10,441 Orthofix Medical shares in Q1 2019, an estimated $548K.
Cambridge Investment Research Advisors first reported a position in Orthofix Medical in Q4 2017 and held it in 2 quarters.
Cambridge Investment Research Advisors's Orthofix Medical position peaked at $605K in Q4 2017.
172 funds tracked by Wall St. Rank held Orthofix Medical as of Q1 2019.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2019, filed 8 May 2019.